Differences in Metabolite-Detecting, Adrenergic, and Immune Gene Expression After Moderate Exercise in Patients With Chronic Fatigue Syndrome, Patients With Multiple Sclerosis, and Healthy Controls

被引:48
作者
White, Andrea T. [2 ,4 ]
Light, Alan R. [1 ,3 ]
Hughen, Ronald W. [1 ]
VanHaitsma, Timothy A. [2 ]
Light, Kathleen C. [1 ]
机构
[1] Univ Utah, Dept Anesthesiol, Salt Lake City, UT 84132 USA
[2] Univ Utah, Dept Exercise & Sport Sci, Salt Lake City, UT 84132 USA
[3] Univ Utah, Dept Neurosci, Salt Lake City, UT 84132 USA
[4] Univ Utah, Inst Brain, Salt Lake City, UT 84132 USA
来源
PSYCHOSOMATIC MEDICINE | 2012年 / 74卷 / 01期
基金
美国国家卫生研究院;
关键词
fatigue; real-time PCR; Fatigue Impact Scale; POSTEXERTIONAL MALAISE; AUTONOMIC DYSFUNCTION; INTERFERON-BETA; TNF-ALPHA; PAIN; FIBROMYALGIA; MUSCLE; ABNORMALITIES; DYSREGULATION; HYPERALGESIA;
D O I
10.1097/PSY.0b013e31824152ed
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Chronic fatigue syndrome (CFS) and multiple sclerosis (MS) are characterized by debilitating fatigue, yet evaluation of this symptom is subjective. We examined metabolite-detecting, adrenergic, and immune gene expression (messenger ribonucleic acid [mRNA]) in patients with CFS (n = 22) versus patients with MS (n = 20) versus healthy controls (n = 23) and determined their relationship to fatigue and pain before and after exercise. Methods: Blood samples and fatigue and pain ratings were obtained at baseline and 0.5, 8, 24, and 48 hours after sustained moderate exercise. Leukocyte mRNA of four metabolite-detecting receptors (acid-sensing ion channel 3, purinergic type 2X4 and 2X5 receptors, and transient receptor potential vanilloid type 1) and four adrenergic (alpha-2a, beta-1, and beta-2 receptors and catechol-O-methyltransferase) and five immune markers (CD14, toll-like receptor 4 [TLR4], interleukin [IL] 6, IL-10, and lymphotoxin alpha) was examined using quantitative polymerase chain reaction. Results: Patients with CFS had greater postexercise increases in fatigue and pain (10Y29 points above baseline, p < .001) and greater mRNA increases in purinergic type 2X4 receptor, transient receptor potential vanilloid type 1, CD14, and all adrenergic receptors than controls (mean T standard error = 1.3 +/- 0.14-to 3.4 +/- 0.90-fold increase above baseline, p = .04-.005). Patients with CFS with comorbid fibromyalgia (n = 18) also showed greater increases in acid-sensing ion channel 3 and purinergic type 2X5 receptors (p < .05). Patients with MS had greater postexercise increases than controls in beta-1 and beta-2 adrenergic receptor expressions (1.4 +/- 0.27- and 1.3 +/- 0.06-fold increases, respectively, p = .02 and p < .001) and greater decreases in TLR4 (p = .02). In MS, IL-10 and TLR4 decreases correlated with higher fatigue scores. Conclusions: Postexercise mRNA increases in metabolite-detecting receptors were unique to patients with CFS, whereas both patients with MS and patients with CFS showed abnormal increases in adrenergic receptors. Among patients with MS, greater fatigue was correlated with blunted immune marker expression.
引用
收藏
页码:46 / 54
页数:9
相关论文
共 52 条
[1]   Sensing Muscle Ischemia: Coincident Detection of Acid and ATP via Interplay of Two Ion Channels [J].
Birdsong, William T. ;
Fierro, Leonardo ;
Williams, Frank G. ;
Spelta, Valeria ;
Naves, Ligia A. ;
Knowles, Michelle ;
Marsh-Haffner, Josephine ;
Adelman, John P. ;
Almers, Wolfhard ;
Elde, Robert P. ;
McCleskey, Edwin W. .
NEURON, 2010, 68 (04) :739-749
[2]   Autonomic dysfunction in patients with fibromyalgia: Application of power spectral analysis of heart rate variability [J].
Cohen, H ;
Neumann, L ;
Shore, M ;
Amir, M ;
Cassuto, Y ;
Buskila, D .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2000, 29 (04) :217-227
[3]   MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue [J].
Colombo, B ;
Boneschi, FM ;
Rossi, P ;
Rovaris, M ;
Maderna, L ;
Filippi, M ;
Comi, G .
JOURNAL OF NEUROLOGY, 2000, 247 (07) :506-509
[4]   A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis [J].
Comabella, M. ;
Luenemann, J. D. ;
Rio, J. ;
Sanchez, A. ;
Lopez, C. ;
Julia, E. ;
Fernandez, M. ;
Nonell, L. ;
Camina-Tato, M. ;
Deisenhammer, F. ;
Caballero, E. ;
Tortola, M. T. ;
Prinz, M. ;
Montalban, X. ;
Martin, R. .
BRAIN, 2009, 132 :3353-3365
[5]   The influence of aerobic fitness and fibromyalgia on cardiorespiratory and perceptual responses to exercise in patients with chronic fatigue syndrome [J].
Cook, Dane B. ;
Nagelkirk, Paul R. ;
Poluri, Ashok ;
Mores, John ;
Natelson, Benjamin H. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (10) :3351-3362
[6]   Identification of the Synthetic Cannabinoid R(+) WIN55,212-2 as a Novel Regulator of IFN Regulatory Factor 3 Activation and IFN-β Expression RELEVANCE TO THERAPEUTIC EFFECTS IN MODELS OF MULTIPLE SCLEROSIS [J].
Downer, Eric J. ;
Clifford, Eileen ;
Gran, Bruno ;
Nel, Hendrik J. ;
Fallon, Padraic G. ;
Moynagh, Paul N. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (12) :10316-10328
[7]  
Elenkov IJ, 2000, PHARMACOL REV, V52, P595
[8]   Neurohormonal-cytokine interactions: Implications for inflammation, common human diseases and well-being [J].
Elenkov, Ilia J. .
NEUROCHEMISTRY INTERNATIONAL, 2008, 52 (1-2) :40-51
[9]   TNF-α and -β gene polymorphisms in multiple sclerosis:: A highly significant role for determinants in the first intron of the TNF-β gene [J].
Fernandes, JAM ;
Vedeler, CA ;
Myhr, KM ;
Nyland, H ;
Pandey, JP .
AUTOIMMUNITY, 2002, 35 (06) :377-380
[10]   THE IMPACT OF FATIGUE ON PATIENTS WITH MULTIPLE-SCLEROSIS [J].
FISK, JD ;
PONTEFRACT, A ;
RITVO, PG ;
ARCHIBALD, CJ ;
MURRAY, TJ .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1994, 21 (01) :9-14